Elsevier

Neuroscience Letters

Volume 146, Issue 2, 9 November 1992, Pages 187-190
Neuroscience Letters

Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis

https://doi.org/10.1016/0304-3940(92)90074-HGet rights and content

Abstract

Low doses of quinolinic acid (QUIN) administered intracerebroventricularly (ICV) to rats produced either no damage or mild to moderate damage in the pyramidal cell layer of the hippocampus and resulted in mild, limbic seizures in the majority of animals treated. The same dose of QUIN following ICV pretreatment with the nitric oxide synthase inhibitor N-nitro-l-arginine (NARG), produced extensive hippocampal lesions with complete loss of the pyramidal layer in 50% of the animals, and moderate damage with total neuronal loss in areas CA1 and CA3 in the remainder of the group. Animals treated with both NARG and QUIN also exhibited a greater incidence of severe convulsive behavior (911) and 3 deaths. Pretreatment with the nitric oxide-generating drug molsidomine attenuated the enhanced toxicity observed with combined NARG-QUIN treatment, resulting primarily in no detectable hippocampal damages and mild seizures resembling those produced by QUIN alone. Administration of NARG alone produced neither seizure activity nor histological evidence of neurotoxicity. We conclude that inhibition of nitric oxide production with NARG potentiates the neurotoxicity of quinolinic acid in the rat hippocampus.

References (23)

  • D.S. Bredt et al.

    Localization of nitric oxide synthase indicating a neural role for nitric oxide

    Nature

    (1990)
  • Cited by (75)

    • The Role of nitric oxide in convulsions induced by lindane in rats

      2011, Food and Chemical Toxicology
      Citation Excerpt :

      n-nitro-l-arginine methyl ester (L-NAME) is non-selective NOS inhibitor commonly used to decrease NO levels. Since pronconvulsive (Kim et al., 1997; Mülsch et al., 1994; Van Leeuwen et al., 1995) as well as anticonvulsive properties (Haberny et al. 1992; Hrncic et al., 2010; Rondouin et al., 1992; Rondouin et al., 1993) of NO has been reported, the role of NO in epileptogenesis is contradictory. The role of NO in lindane effects is still not investigated.

    • Oxidative stress in anticholinesterase-induced excitotoxicity

      2006, Toxicology of Organophosphate & Carbamate Compounds
    • Oxidative Stress in Anticholinesterase-Induced Excitotoxicity

      2005, Toxicology of Organophosphate and Carbamate Compounds
    • Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain

      2002, Brain Research
      Citation Excerpt :

      For example, increases of nitric oxide (NO) by seizure-producing concentrations of glutamatergic receptor agonists [4,43,48], and AChE inhibitors have been demonstrated [1,30,33,35,37]. Conversely, the results of studies using nitric oxide synthase (NOS) inhibitors indicate that NO may play a role as an endogenous anticonvulsant substance [14,32,40,55]. Other reports show that administration of the NOS inhibitor N-nitro-l-arginine methylester (l-NAME) prevented limbic seizures and related hippocampal damage by tacrine (an anticholinesterase agent) in rats, but not seizures and hippocampal damage caused by KA [2,3].

    View all citing articles on Scopus
    View full text